Simvastatin modulates TNFalpha-induced adhesion molecules expression in human endothelial cells

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Endothelial Cell Biology

Background:

• Leukocyte adhesion and migration into the vascular wall are key events in atherogenesis.
• Endothelial cell adhesion molecules, including VCAM-1 and ICAM-1, are critical mediators of this process.

Purpose of the Study:

• To investigate the effect of simvastatin on VCAM-1 and ICAM-1 expression in human umbilical vein endothelial cells (HUVEC).
• To explore the molecular mechanisms underlying simvastatin's action on these adhesion molecules.

Main Methods:

• HUVEC were stimulated with tumor necrosis factor alpha (TNFα).
• Simvastatin's impact on VCAM-1 and ICAM-1 expression, mRNA levels, NF-κB activation, and PPARα expression was assessed.
• Monocyte and lymphocyte adherence to HUVEC was measured.

Main Results:

• Simvastatin significantly inhibited TNFα-induced VCAM-1 and ICAM-1 expression in a time- and concentration-dependent manner.
• The drug reduced VCAM-1 and ICAM-1 mRNA levels, inhibited NF-κB activation, and enhanced PPARα expression.
• Simvastatin decreased the adherence of monocytes and lymphocytes to HUVEC.

Conclusions:

• Simvastatin effectively inhibits the expression of VCAM-1 and ICAM-1 in endothelial cells.
• These inhibitory effects are mediated through modulation of NF-κB and PPARα pathways.
• Statins may offer vascular benefits by suppressing leukocyte adhesion via reduced expression of key adhesion molecules.